The Coronavirus (COVID-19) clinical samples are a "Category B" material for transportation, defined as an infectious substance that is not in a form generally capable of causing permanent disability or life-threatening or fatal disease in otherwise healthy humans or animals when exposure to it occurs. COVID-19 contaminated waste or reusable material derived from the medical treatment of COVID-19 patients is considered regulated medical waste.
PHMSA's PowerPoint presentation provides a quick reference for medical facilities, clinical laboratories and hazardous waste carriers to safely package and transport COVID-19 specimens, cultures, isolates and medical waste.
Handling and Disposing of COVID-19
Please see important CDC guidance for handling and disposing of COVID-19 and SARS-CoV-2 clinical samples and waste:
Guidance on Workplace Safety
For guidance on workplace safety see:
Because the current COVID-19 pandemic is rapidly evolving, please continue to monitor important public health and response updates at: